leadf
logo-loader
viewFastForward Innovations Limited

FastForward Innovations adds to medical cannabis portfolio with investment in Kanabo IPO

“We are delighted to see another cannabis focussed company listing here in London,” said CEO Ed McDermott

FastForward Innovations Limited -

FastForward Innovations Ltd (LON:FFWD) has added to the burgeoning medical cannabis portion of its portfolio with an investment in Kanabo Group Plc (LON:KNB) as part of its London initial public offer (IPO).

The AIM-listed investment company invested £62,500 as part of Kanabo’s £6mln oversubscribed placing at a price of 6.5 pence.

FastForward’s investment immediately paid off as Kanabo, which boasts that it has the only medically-approved vaporisation device on the market, made its debut on the London Stock Exchange and saw its shares surge over 200% to 19.8p by mid-afternoon on its debut.

Tel Aviv-based Kanabo, which draws upon an Israeli market where cannabis was approved for medical use in the 1990s and a state-regulated medical cannabis program was initiated in 2007, has already started selling its VapePod device, which provides metered dosages of its proprietary cannabis-based oil formulations, as part of a pilot scheme.

As of the first day of dealings, FastForward Innovations had a holding of 961,538 ordinary shares in Kanabo, representing 0.27% of total issued share capital.

The investment further develops the company’s exposure to the medicinal cannabis industry, having invested A$1mln in a placing undertaken by Little Green Pharma Ltd (ASX:LGP) earlier this month.

Emmac, one of Europe’s leading producers and supplier of medicinal cannabis, hemp and other derivative products, has been in the portfolio since March 2019, with FFWD’s first medical cannabis investment being Nuuvera Inc in 2017, which was exited in 2018 after it was taken over.

The portfolio also includes an investment in Yooma, a hemp-based wellness products firm that is planning to partner with some of Pan-Asia’s leading social and e-commerce platforms to create the first hemp and cannabidiol (CBD) lifestyle company in Asia.

Ed McDermott, CEO of FastForward, said: “We are delighted to see another cannabis focussed company listing here in London and, although we are disappointed to have been heavily scaled back in the oversubscribed placing, we are pleased to see Kanabo shares having a strong market debut and look forward to further progress.”

Shares in FFWD were up 5% to 11.2p apiece. 

Quick facts: FastForward Innovations Limited

Price: 10.625 GBX

LSE:FFWD
Market: LSE
Market Cap: £22.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FastForward Innovations Limited named herein, including the promotion by the Company of FastForward Innovations Limited in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: UK suffers record 9.9% slump, Bubble Billionaire and Mode...

The Market Report with Katie Pilbeam.  FTSE 100 slipped in early dealings as the severe impact of coronavirus on the UK economy was highlighted in official figures. London’s blue-chip index dropped 27 to 6,501.   Britain’s economy shrank by a record 9.9% last year as coronavirus...

3 weeks, 4 days ago

2 min read